[1]Liu MP, Ma JY, Pan BR, et al.Study of pancreatic in China[J]WoridChin J Digestol, 2001, 9∶1103-1109.
|
[1]Liu MP, Ma JY, Pan BR, et al.Study of pancreatic in China[J]WoridChin J Digestol, 2001, 9∶1103-1109.
|
[2]Humphreys MJ, Greenhalf W, Neoptolemos JP, et al.The potential forgene therapy in pancreatic cancer[J].Int J Pancreatol, 1999, 26∶5-21.
|
[2]Humphreys MJ, Greenhalf W, Neoptolemos JP, et al.The potential forgene therapy in pancreatic cancer[J].Int J Pancreatol, 1999, 26∶5-21.
|
[3] AJCC Cancer Staging Manual, Fifth Edition, American Joint Committeeon Cancer, American Cancer Society, Lippincott-Raven, 1997.
|
[3] AJCC Cancer Staging Manual, Fifth Edition, American Joint Committeeon Cancer, American Cancer Society, Lippincott-Raven, 1997.
|
[4]任本, 尹立杰, 陈翠萍.立体定向放射治疗肝脏恶性肿瘤临床研究[J]临床消化病杂志, 2002, 14 (4) ∶147.
|
[4]任本, 尹立杰, 陈翠萍.立体定向放射治疗肝脏恶性肿瘤临床研究[J]临床消化病杂志, 2002, 14 (4) ∶147.
|
[5]Sandberg AA, Bachman PL, Andersson R.Results of adjuvant therapy inresected pancreatic cancer[J].Int J Pancreatol, 1997, 21∶31-38.
|
[5]Sandberg AA, Bachman PL, Andersson R.Results of adjuvant therapy inresected pancreatic cancer[J].Int J Pancreatol, 1997, 21∶31-38.
|
[6]Cao YZ, Lu ZH, Yang TN.Stereotactic radiotherapy of malignancies inthorax and abdomen[J].Chinese J Clinical Oncology, 2000, 670-673.
|
[6]Cao YZ, Lu ZH, Yang TN.Stereotactic radiotherapy of malignancies inthorax and abdomen[J].Chinese J Clinical Oncology, 2000, 670-673.
|
[7]Wang CS, Yue JH, Yang XG et al.Conformal radiation therapy of accel-erated fraction for 23 patients with pancreatic carcinoma[J].Chinese JClinical Oncology, 2000, 667-669.
|
[7]Wang CS, Yue JH, Yang XG et al.Conformal radiation therapy of accel-erated fraction for 23 patients with pancreatic carcinoma[J].Chinese JClinical Oncology, 2000, 667-669.
|
[1] | Xiaofang ZHAO, Aimin ZHANG, Wengang LI, Jing SUN, Xiaoyun CHANG, Tao ZHANG, Weiping HE, Xuezhang DUAN. Efficacy and safety of stereotactic body radiation therapy in treatment of patients with unresectable cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2023, 39(11): 2657-2662. doi: 10.3969/j.issn.1001-5256.2023.11.021 |
[2] | Wenjun LIU, Dan DU, Baojie CHEN, Ting YAO, Xianfu LI. Application of stereotactic body radiotherapy in small hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(5): 1212-1215. doi: 10.3969/j.issn.1001-5256.2021.05.050 |
[3] | Wang Le, Liu LiXin, Guo XiaoHong. Value of contrast-enhanced endoscopic ultrasonography in the differential diagnosis of mass-type chronic pancreatitis and pancreatic cancer:A Meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2246-2251. doi: 10.3969/j.issn.1001-5256.2019.10.023 |
[4] | Li TianTian, Sun Jing, Wang Quan, Ding JunQiang, Wang Jia, Xue Hui, Zhang Tao, Duan XueZhang. Clinical effect of stereotactic body radiotherapy in treatment of patients with small hepatocellular carcinoma and related prognostic factors[J]. Journal of Clinical Hepatology, 2018, 34(8): 1702-1706. doi: 10.3969/j.issn.1001-5256.2018.08.022 |
[5] | Zhang Tao, Sun Jing, He WeiPing, Li Huan, Wang Hui, Sun YingZhe, Po JunJie, Zhang JunHua, Xu HuiJun, Duan XueZhang. Clinical effect of Cyber Knife stereotactic radiosurgery in treatment of patients with small hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2017, 33(4): 694-698. doi: 10.3969/j.issn.1001-5256.2017.04.019 |
[6] | Sun Jing, Po JunJie, Fan YuZe, He WeiPing, Li Huan, Sun YingZhe, Wang Hui, Duan XueZhang. Effect of stereotactic body radiotherapy versus intensity-modulated radiotherapy in primary liver cancer patients with secondary malignant tumor of vertebra[J]. Journal of Clinical Hepatology, 2016, 32(6): 1135-1138. doi: 10.3969/j.issn.1001-5256.2016.06.023 |
[7] | Ji HongBing, Chen ZhongHua. Therapeutic effect of gemcitabine hydrochloride combined with stereotactic radiotherapy for locally advanced pancre-atic cancer[J]. Journal of Clinical Hepatology, 2016, 32(3): 537-540. doi: 10.3969/j.issn.1001-5256.2016.03.030 |
[8] | Group of Pancreas Surgery, Chinese Society of Surgery, Chinese Medical Association. Guidelines for the management of pancreatic cancer (2014)[J]. Journal of Clinical Hepatology, 2014, 30(12): 1240-1245. doi: 10.3969/j.issn.1001-5256.2014.12.003 |
[9] | Wang NanYa, Zhao HengJun, Zheng XiaoHui, Li Wei, Wang GuanJun. Clinical study of high-intensity focused ultrasound therapy in combination with gemcitabine for unresectable pancreatic carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(11): 1193-1195. |
[10] | Ruan RunSheng, Xu KeCheng. Immunotherapy of pancreatic cancer[J]. Journal of Clinical Hepatology, 2010, 26(5): 462-467. |
[11] | Wei LiRong, Liu JingYuan, Liu Zhuang. Short-term efficacy of entecavir in the treatment of chronic severe hepatitis B [J]. Journal of Clinical Hepatology, 2009, 25(1): 56-58. |
[14] | Li ChunSheng, Ni CanRong. Expression of S100A4 and E-cadherin in pancreatic carcinoma and their relationship study[J]. Journal of Clinical Hepatology, 2006, 22(3): 207-208. |
[19] | Yuan ZhangJi, Yang Lei, Yao Cheng, Wang GuanJun. Observation of high intensity focused ultrasound treating 40 cases of cancer of pancreas[J]. Journal of Clinical Hepatology, 2003, 19(3): 145-146. |
[20] | Guo ZhanWen, Li Yu, Yan Ying, Tian QiHe, Xu Rui. Clinical study of 3-dimensional conformal radiotherapy on primary liver cancer.[J]. Journal of Clinical Hepatology, 2002, 18(3): 164-165. |